14 results match your criteria: "Azienda Ospedaliero-Universitaria di Ferrara Arcispedale S. Anna[Affiliation]"
Br J Clin Pharmacol
April 2024
Hospital Pharmacy, Azienda Ospedaliero-Universitaria di Ferrara Arcispedale S. Anna, Cona, Ferrara, Italy.
ESC Heart Fail
October 2023
Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
Aims: This study aimed to determine whether any change occurred over time in level of evidence (LoE) of therapeutic interventions supporting heart failure (HF) and other European Society of Cardiology guideline recommendations.
Methods And Results: We selected topics with at least three documents released between 2008 and April 2022. Classes of recommendations (CoR) and supporting LoE related to therapeutic interventions within each document were collected and compared over time.
Intern Emerg Med
January 2023
Cardiology Unit, "Card. G. Panico" Hospital, Tricase, Italy.
Background: The subsequent waves of the COVID-19 pandemic in Italy had a major impact on cardiac care.
Methods: A survey to evaluate the dynamic changes in arrhythmia care during the first five waves of COVID-19 in Italy (first: March-May 2020; second: October 2020-January 2021; third: February-May 2021; fourth: June-October 2021; fifth: November 2021-February 2022) was launched.
Results: A total of 127 physicians from arrhythmia centers (34% of Italian centers) took part in the survey.
Eur J Heart Fail
April 2022
Scientific Department, MTA Group, Lugano, Switzerland.
Eur J Intern Med
May 2022
Scientific Department, Medical Trial Analysis, Lugano, Switzerland.
The use of catheter ablation of atrial fibrillation (AFA) is increasing and it has now been extended to include higher risk patients with heart failure (HF), based on evidence from observational studies and meta-analyses of randomized controlled trials (RCTs) indicating it as safe and beneficial in terms of quality of life, AF recurrence and hospital readmissions in the short-to-middle term. However, the RCTs so far have been relatively small with short follow-up, and few larger trials with long follow-up inconclusive about hard outcomes for large patient crossover undermining the robustness of the results. Importantly, most RCTs involved HF patients with reduced left ventricular ejection fraction (HFrEF).
View Article and Find Full Text PDFJ Clin Med
October 2021
Department of Biomedical, Metabolic and Neural Sciences, Cardiology Division, University of Modena and Reggio Emilia, Policlinico Di Modena, 41121 Modena, Italy.
The aim of this survey, which was open to all Italian cardiologists involved in arrhythmia, was to assess common practice regarding sedation and analgesia in interventional electrophysiology procedures in Italy. The survey consisted of 28 questions regarding the approach to sedation used for elective direct-current cardioversion (DCC), subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation, atrial fibrillation (AF) ablation, ventricular tachycardia (VT) ablation, and transvenous lead extraction procedures. A total of 105 cardiologists from 92 Italian centres took part in the survey.
View Article and Find Full Text PDFEur J Intern Med
October 2021
Maria Cecilia Hospital, GVM Care&Research, Cotignola, Italy; Medical Trial Analysis, Lugano, Switzerland.
Aims: Our aim was to describe the electrocardiographic features of critical COVID-19 patients.
Methods And Results: We carried out a multicentric, cross-sectional, retrospective analysis of 431 consecutive COVID-19 patients hospitalized between 10 March and 14 April 2020 who died or were treated with invasive mechanical ventilation. This project is registered on ClinicalTrials.
Intern Emerg Med
November 2020
Department of Heart and Vessels, Ospedale Di Circolo-University of Insubria, Varese, Italy.
COVID-19 outbreak had a major impact on the organization of care in Italy, and a survey to evaluate provision of for arrhythmia during COVID-19 outbreak (March-April 2020) was launched. A total of 104 physicians from 84 Italian arrhythmia centres took part in the survey. The vast majority of participating centres (95.
View Article and Find Full Text PDFHead Neck
January 2020
Department of Radiation Oncology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy.
Europace
October 2019
Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti n. 9, Bologna, Italy.
Aims: The benefit of prolonged implantable cardioverter-defibrillator (ICD)/cardiac resynchronization therapy defibrillator (CRT-D) therapy following device replacement is hindered by clinical and procedure-related adverse events (AEs). Adverse events rate is highest in more complex devices and at upgrades, as per the REPLACE registry experience, but is changing owing to the improvement in device technology and medical care. We aimed at understanding the extent and type of AEs in a contemporary Italian population.
View Article and Find Full Text PDFEuropace
September 2018
Department of Cardiovascular Sciences, Catholic University of Sacred Heart Rome, Via Largo Francesco Vito, 1, Rome, Italy.
Aim: Ventricular tachycardia (VT)/ventricular fibrillation (VF) occurrence after cardiac resynchronization therapy-defibrillator (CRT-D) replacement is unknown; hence, there is no practical guideline to recommend either CRT-D or CRT-pacemaker at the time of device replacement. We observed the 1-year VT/VF occurrence after CRT-D replacement in a subanalysis of the Detect Long-term Complications after ICD Replacement (DECODE) registry.
Methods And Results: A total of 332 consecutive patients who had undergone CRT-D replacement from 2013 to 2015 were enrolled in 36 Italian centres.
BMC Health Serv Res
May 2007
Azienda Ospedaliero Universitaria di Ferrara Arcispedale S. Anna, corso Giovecca 203, Ferrara, Italy.
Background: By means of the ICONAS project, the Healthcare Agency of an Italian Region developed, and used a standardised questionnaire to quantify the organisational climate. The aims of the project were (a) to investigate whether the healthcare institutions were interested in measuring climate, (b) to estimate the range of applicability and reliability of the instrument, (c) to analyse the dimensions of climate among healthcare personnel, (d) to assess the differences among employees with different contractual positions.
Methods: The anonymous questionnaire containing 50 items, each with a scale from 1 to 10, was offered to the healthcare organisations, to be compiled during ad hoc meetings.